Pacific Biosciences Of California (PACB) Gains from Investment Securities (2022 - 2025)
Pacific Biosciences Of California (PACB) posted quarterly Gains from Investment Securities of -$18.7 million for Q1 2025, down 26614.29% year-over-year from N/an in Q1 2024, and down 858.97% quarter-over-quarter from -$2.0 million in Q4 2024.
Pacific Biosciences Of California (PACB) Gains from Investment Securities (2022 - 2025) Analysis & Trends
Pacific Biosciences Of California's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at -$18.7 million for Q1 2025.
- In Q1 2025, Gains from Investment Securities fell 26614.29% year-over-year to -$18.7 million; the TTM figure through Dec 2025 stood at -$18.7 million (down 2100.0% YoY), while the FY2025 annual figure was -$18.7 million, down 2100.0% from the prior year.
- Gains from Investment Securities for Q1 2025 stood at -$18.7 million, down from -$2.0 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $12.3 million in Q1 2023, with the low at -$18.7 million in Q1 2025.
- The 4-year median for Gains from Investment Securities is $515000.0 (2023), against an average of -$176083.3.
- The sharpest annual moves came in 2023 and 2025: Gains from Investment Securities surged 1252.96% in 2023, then tumbled 26614.29% in 2025.
- Pacific Biosciences Of California's Gains from Investment Securities stood at $4.6 million in 2022, then tumbled by 76.08% to $1.1 million in 2023, then sank by 277.27% to -$2.0 million in 2024, then slumped by 858.97% to -$18.7 million in 2025.
- Business Quant data shows PACB's Gains from Investment Securities at -$18.7 million in Q1 2025, -$2.0 million in Q4 2024, and $1.2 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 399.19 Mn | 162.32 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -18.70 Mn |
| Mar 31, 2025 | -18.70 Mn |
| Dec 31, 2024 | -1.95 Mn |
| Dec 31, 2024 | -1.95 Mn |
| Sep 30, 2024 | 1.17 Mn |
| Sep 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | -70,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Dec 31, 2023 | 1.10 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | -271,000.00 |
| Sep 30, 2023 | -271,000.00 |
| Jun 30, 2023 | 1.98 Mn |
| Jun 30, 2023 | 1.98 Mn |
| Mar 31, 2023 | 12.26 Mn |
| Mar 31, 2023 | 12.26 Mn |
| Dec 31, 2022 | 4.60 Mn |
| Dec 31, 2022 | 4.60 Mn |
| Sep 30, 2022 | 4.28 Mn |
| Sep 30, 2022 | 4.28 Mn |